Furthermore, in our attempt to identify potential pathogenic genes for oral MPCs, we found that in addition to commonly detected gene mutations such as TP53, CASP8, and MUC16, there were also relatively rare gene mutations compared to OSCC or HNSCC. This evidence concerns the gene TP53 and head and neck squamous cell carcinoma.